While we have previously reported that TIE-2 and VEGFR kinase activities drive immunosuppressive function of TEM in human breast Cancer [38], in this study, we investigated the contribution of these pathways along with TGFBR-1 and TNF-R1 pathways to TEM pro-angiogenic activity. Here, TEK is linked to breast carcinoma.